Skip to content

Nektar Therapeutics

American healthcare company

NKTR Nasdaq SEC CIK 906709

Follow Nektar Therapeutics Weekly email: filings, results, news

News

4 stories filed under Nektar Therapeutics, grouped into ongoing threads

Sells

Thread · 2 stories

Nektar Therapeutics chief R&D officer Zalevsky sells $13,388 in shares

Markets 34 d ago 2 sources

Nektar Therapeutics CEO Howard W. Robin sells $30,087 in stock

Markets 35 d ago

More coverage

Nektar’s (NKTR) Billion-Dollar Balance Sheet Faces A Multi-Year Test

Markets 28 d ago

Nektar Therapeutics (NKTR) Q2 2026 Earnings Call Transcript

Earnings 41 d ago

Profile

Headquarters: SAN FRANCISCO, CA, United States
Founded: 1990
Sector: Healthcare
Industry: Pharmaceutical Preparations
Website: nektar.com

Peers

Where this page comes from

Profile · SEC EDGAR, Wikidata

News · 4 stories clustered from the RSS aggregator